Involvement of caveolin in probucol-induced reduction in hERG plasma-membrane expression

Jun Guo, Xian Li, Heidi Shallow, Jianmin Xu, Tonghua Yang, Hamid Massaeli, Wentao Li, Tao Sun, Grant N. Pierce, Shetuan Zhang

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The human ether-á-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier K+ current (IKr) important for cardiac repolarization. Dysfunction of the hERG channel causes long QT syndrome (LQTS). Although diverse compounds reduce the hERG current (IhERG) by blocking the channel, probucol, a cholesterol-lowering drug that causes LQTS, reducesIhERG by decreasing plasma-membrane hERG protein expression. Here, we investigated the mechanisms of probucol effects on hERG expression levels. Our data demonstrate that probucol accelerated the degradation of mature hERG channels, which associated with caveolin-1 (Cav1) in hERG-expressing HEK cells. In human embryonic kidney (HEK) cells without hERG expression, probucol promoted endogenous Cav1 degradation. In hERG-expressing HEK cells, overexpression of Cav1 enhanced, whereas knockdown of Cav1 impeded, probucol-induced reduction of mature hERG channels. Thus, probucol reduces hERG expression through accelerating Cav1 turnover. The effects of probucol on Cav1 and hERG result from probucol's cholesterol-disrupting action, because low-density lipoprotein (LDL), a potent cholesterol carrier, effectively prevented probucol-induced reduction of IhERG in hERG-expressing HEK cells and of IKr in neonatal rat cardiomyocytes. Our data provide evidence that targeting hERG-interacting protein caveolin represents a novel mechanism for drugs to decrease hERG expression and cause LQTS. Cipyright

Original languageEnglish
Pages (from-to)806-813
Number of pages8
JournalMolecular Pharmacology
Volume79
Issue number5
DOIs
Publication statusPublished - 1 May 2011
Externally publishedYes

Fingerprint

Probucol
Caveolins
Ether
Cell Membrane
Genes
Caveolin 1
Long QT Syndrome
Gene Expression
Kidney
Cholesterol

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Involvement of caveolin in probucol-induced reduction in hERG plasma-membrane expression. / Guo, Jun; Li, Xian; Shallow, Heidi; Xu, Jianmin; Yang, Tonghua; Massaeli, Hamid; Li, Wentao; Sun, Tao; Pierce, Grant N.; Zhang, Shetuan.

In: Molecular Pharmacology, Vol. 79, No. 5, 01.05.2011, p. 806-813.

Research output: Contribution to journalArticle

Guo, J, Li, X, Shallow, H, Xu, J, Yang, T, Massaeli, H, Li, W, Sun, T, Pierce, GN & Zhang, S 2011, 'Involvement of caveolin in probucol-induced reduction in hERG plasma-membrane expression', Molecular Pharmacology, vol. 79, no. 5, pp. 806-813. https://doi.org/10.1124/mol.110.069419
Guo, Jun ; Li, Xian ; Shallow, Heidi ; Xu, Jianmin ; Yang, Tonghua ; Massaeli, Hamid ; Li, Wentao ; Sun, Tao ; Pierce, Grant N. ; Zhang, Shetuan. / Involvement of caveolin in probucol-induced reduction in hERG plasma-membrane expression. In: Molecular Pharmacology. 2011 ; Vol. 79, No. 5. pp. 806-813.
@article{b4d38360c3ba434a893e3963f83be138,
title = "Involvement of caveolin in probucol-induced reduction in hERG plasma-membrane expression",
abstract = "The human ether-{\'a}-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier K+ current (IKr) important for cardiac repolarization. Dysfunction of the hERG channel causes long QT syndrome (LQTS). Although diverse compounds reduce the hERG current (IhERG) by blocking the channel, probucol, a cholesterol-lowering drug that causes LQTS, reducesIhERG by decreasing plasma-membrane hERG protein expression. Here, we investigated the mechanisms of probucol effects on hERG expression levels. Our data demonstrate that probucol accelerated the degradation of mature hERG channels, which associated with caveolin-1 (Cav1) in hERG-expressing HEK cells. In human embryonic kidney (HEK) cells without hERG expression, probucol promoted endogenous Cav1 degradation. In hERG-expressing HEK cells, overexpression of Cav1 enhanced, whereas knockdown of Cav1 impeded, probucol-induced reduction of mature hERG channels. Thus, probucol reduces hERG expression through accelerating Cav1 turnover. The effects of probucol on Cav1 and hERG result from probucol's cholesterol-disrupting action, because low-density lipoprotein (LDL), a potent cholesterol carrier, effectively prevented probucol-induced reduction of IhERG in hERG-expressing HEK cells and of IKr in neonatal rat cardiomyocytes. Our data provide evidence that targeting hERG-interacting protein caveolin represents a novel mechanism for drugs to decrease hERG expression and cause LQTS. Cipyright",
author = "Jun Guo and Xian Li and Heidi Shallow and Jianmin Xu and Tonghua Yang and Hamid Massaeli and Wentao Li and Tao Sun and Pierce, {Grant N.} and Shetuan Zhang",
year = "2011",
month = "5",
day = "1",
doi = "10.1124/mol.110.069419",
language = "English",
volume = "79",
pages = "806--813",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "5",

}

TY - JOUR

T1 - Involvement of caveolin in probucol-induced reduction in hERG plasma-membrane expression

AU - Guo, Jun

AU - Li, Xian

AU - Shallow, Heidi

AU - Xu, Jianmin

AU - Yang, Tonghua

AU - Massaeli, Hamid

AU - Li, Wentao

AU - Sun, Tao

AU - Pierce, Grant N.

AU - Zhang, Shetuan

PY - 2011/5/1

Y1 - 2011/5/1

N2 - The human ether-á-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier K+ current (IKr) important for cardiac repolarization. Dysfunction of the hERG channel causes long QT syndrome (LQTS). Although diverse compounds reduce the hERG current (IhERG) by blocking the channel, probucol, a cholesterol-lowering drug that causes LQTS, reducesIhERG by decreasing plasma-membrane hERG protein expression. Here, we investigated the mechanisms of probucol effects on hERG expression levels. Our data demonstrate that probucol accelerated the degradation of mature hERG channels, which associated with caveolin-1 (Cav1) in hERG-expressing HEK cells. In human embryonic kidney (HEK) cells without hERG expression, probucol promoted endogenous Cav1 degradation. In hERG-expressing HEK cells, overexpression of Cav1 enhanced, whereas knockdown of Cav1 impeded, probucol-induced reduction of mature hERG channels. Thus, probucol reduces hERG expression through accelerating Cav1 turnover. The effects of probucol on Cav1 and hERG result from probucol's cholesterol-disrupting action, because low-density lipoprotein (LDL), a potent cholesterol carrier, effectively prevented probucol-induced reduction of IhERG in hERG-expressing HEK cells and of IKr in neonatal rat cardiomyocytes. Our data provide evidence that targeting hERG-interacting protein caveolin represents a novel mechanism for drugs to decrease hERG expression and cause LQTS. Cipyright

AB - The human ether-á-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier K+ current (IKr) important for cardiac repolarization. Dysfunction of the hERG channel causes long QT syndrome (LQTS). Although diverse compounds reduce the hERG current (IhERG) by blocking the channel, probucol, a cholesterol-lowering drug that causes LQTS, reducesIhERG by decreasing plasma-membrane hERG protein expression. Here, we investigated the mechanisms of probucol effects on hERG expression levels. Our data demonstrate that probucol accelerated the degradation of mature hERG channels, which associated with caveolin-1 (Cav1) in hERG-expressing HEK cells. In human embryonic kidney (HEK) cells without hERG expression, probucol promoted endogenous Cav1 degradation. In hERG-expressing HEK cells, overexpression of Cav1 enhanced, whereas knockdown of Cav1 impeded, probucol-induced reduction of mature hERG channels. Thus, probucol reduces hERG expression through accelerating Cav1 turnover. The effects of probucol on Cav1 and hERG result from probucol's cholesterol-disrupting action, because low-density lipoprotein (LDL), a potent cholesterol carrier, effectively prevented probucol-induced reduction of IhERG in hERG-expressing HEK cells and of IKr in neonatal rat cardiomyocytes. Our data provide evidence that targeting hERG-interacting protein caveolin represents a novel mechanism for drugs to decrease hERG expression and cause LQTS. Cipyright

UR - http://www.scopus.com/inward/record.url?scp=79955047914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955047914&partnerID=8YFLogxK

U2 - 10.1124/mol.110.069419

DO - 10.1124/mol.110.069419

M3 - Article

VL - 79

SP - 806

EP - 813

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 5

ER -